Clinical Trials in Conway, Arkansas

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

NCT ID: NCT06528314

This clinical trial is studying a new medication called efruxifermin (EFX) for people with compensated cirrhosis caused by nonalcoholic steatohepatitis (NASH) or metabolic dysfunction-associated st...

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

NCT ID: NCT06318169

The ENLIGHTEN-Fibrosis trial is studying a new treatment called pegozafermin for adults with a liver condition known as Metabolic Dysfunction-associated Steatotic Liver Disease (MASH), which can al...

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

NCT ID: NCT03072927

This clinical trial is studying a procedure called MILD® (Minimally Invasive Lumbar Decompression) for patients with a condition known as lumbar spinal stenosis, which means there is pressure on th...

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NCT ID: NCT06215716

This clinical trial is studying a medication called efruxifermin (EFX) to see if it can help people with non-cirrhotic Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steato...

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

NCT ID: NCT05327127

This clinical trial is looking at a new treatment for adults with Nonalcoholic Steatohepatitis (NASH), a liver condition that can lead to serious health issues. The study aims to evaluate the effec...

Rhythm Express Wearable System vs. Simultaneous Polysomnography for the Diagnosis of Obstructive Sleep Apnea in Adults With Suspected or Observed Atrial Fibrillation

NCT ID: NCT06907888

This clinical trial is studying a new device called the Rhythm Express Wearable System, which is designed to help detect obstructive sleep apnea (OSA) in adults who may also have a heart condition ...

A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)

NCT ID: NCT04636814

This clinical trial, known as the PILLAR study, is looking at the effectiveness and safety of a new medication called CHF6001 (also known as Tanimilast) when added to existing treatments for people...

Sport-Related Concussion Recovery in Athletes

NCT ID: NCT06852300

A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

NCT ID: NCT04849728

This clinical trial, called NATiV3, is studying a new treatment called lanifibranor for adults with a liver condition known as Nonalcoholic Steatohepatitis (NASH) and fibrosis stages F2 or F3. NASH...